| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0879 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.05 |
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.05 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.05 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.05 |